Debut Plus

₹257.5

▼ -0.54 -0.21%

17 Jul 2026

BSE Listed

Samrat Pharmachem Ltd. (530125)

Volume: 548Avg Vol 1W: 525Avg Vol 1M: 4,42152W Range:₹190₹383.95
BSE www.samratpharmachem.com
Key Ratios
Checked just now
Market Cap₹80 Cr
Current Price₹257.5
Previous Close₹258.04
High / Low (52w)₹383.95 / ₹190
Volume548
Avg Vol (1W)525
Avg Vol (1M)4,421
Stock P/E—
Book Value₹220.67
Dividend Yield0%
ROE-485.78%
ROA-266.84%
Revenue (TTM)—
Revenue Growth—
Profit Margin-114.59%
Total Debt—
Shares Outstanding0 Cr
Face Value—
EPS (TTM)₹0
P/B1.17
Debt / Equity0.13
50 DMA₹223.29
200 DMA₹235.96
Day change-0.21%
Price Chart
₹257.5▼ 31.66% · 1Y
₹392₹19528K
2025-07-17
2026-07-17

20-day avg volume: 5K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹81 Cr₹70 Cr₹64 Cr₹71 Cr₹76 Cr₹79 Cr₹63 Cr₹72 Cr
EBITDA₹3 Cr₹4 Cr₹4 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹-2 Cr
Net Profit₹2 Cr₹3 Cr₹3 Cr₹0 Cr₹0 Cr₹-1 Cr₹0 Cr₹-2 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹93 Cr₹112 Cr₹138 Cr₹179 Cr₹222 Cr₹311 Cr₹283 Cr₹287 Cr
EBITDA₹6 Cr₹3 Cr₹7 Cr₹9 Cr₹24 Cr₹24 Cr₹3 Cr₹11 Cr
Net Profit₹3 Cr₹2 Cr₹4 Cr₹5 Cr₹17 Cr₹17 Cr₹2 Cr₹7 Cr
EPS10.414.9713.7117.2655.6253.83723.02
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹41 Cr₹40 Cr₹58 Cr₹57 Cr₹85 Cr₹117 Cr₹122 Cr₹121 Cr
Total Liabilities₹22 Cr₹20 Cr₹34 Cr₹28 Cr₹38 Cr₹53 Cr₹57 Cr₹50 Cr
Equity₹19 Cr₹20 Cr₹24 Cr₹30 Cr₹47 Cr₹63 Cr₹65 Cr₹72 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹7 Cr₹19 Cr₹0 Cr₹12 Cr₹-9 Cr
Investing₹-3 Cr₹-1 Cr₹-3 Cr₹0 Cr₹0 Cr
Financing₹-2 Cr₹-2 Cr₹10 Cr₹-11 Cr₹0 Cr
Free Cash Flow₹7 Cr₹19 Cr₹0 Cr₹12 Cr₹-9 Cr
Shareholding
Promoter 49.09% Institutions 3.24% Public 47.67%
Efficiency & Working Capital
ROCE-2.6%
Interest Coverage15.8
Dividend Payout—
Debtor Days72 d
Inventory Days49 d
Payable Days49 d
Cash Conversion Cycle71 d
Working Capital Days121 d
Shareholding Details

As of 2026-06-30

Promoter49.1%
FII3.2%
DII0%
Institutions3.2%
Public47.7%
Promoter Pledge0%
No. of Shareholders6,330
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters48.6%48.6%48.6%48.6%49%49.1%49.1%49.1%49.1%49.1%49.1%49.1%
FIIs0%0%3.2%3.2%3.2%3.2%3.2%0%3.2%3.2%3.2%3.2%
DIIs0%0%0.2%0.2%0.2%0%0%3.2%0%0%0%0%
Public51.4%51.4%47.9%47.9%47.6%47.7%47.7%47.7%47.7%47.7%47.7%47.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders8,4458,0657,4787,1696,9846,8446,7856,7526,6996,4886,3116,330
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Lalit Damodar MehtaShareholding of Promoter and Promoter Group14%4,31,498
Rajesh Lalit MehtaShareholding of Promoter and Promoter Group12.4%3,83,542
Premal Lalit MehtaShareholding of Promoter and Promoter Group5.7%1,75,281
Kaushal Lalit MehtaShareholding of Promoter and Promoter Group4.5%1,39,065
Jaya Lalit MehtaShareholding of Promoter and Promoter Group3.9%1,19,300
Sangeetha SPublic Shareholding3.3%1,01,010
Rupal Rajesh MehtaShareholding of Promoter and Promoter Group2.7%82,182
Falguni Kaushal MehtaShareholding of Promoter and Promoter Group2.2%66,400
Megh Rajesh MehtaShareholding of Promoter and Promoter Group1.8%54,356
Kalpana Premal MehtaShareholding of Promoter and Promoter Group1.6%50,600
Lalit Kumar V JainPublic Shareholding1.2%37,747
Sharad Kanayalal ShahPublic Shareholding1.1%35,000
Maitri Megh MehtaShareholding of Promoter and Promoter Group0.5%14,543
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Lalit Damodar Mehta00%2026-06-30
Rajesh Lalit Mehta00%2026-06-30
Premal Lalit Mehta00%2026-06-30
Kaushal Lalit Mehta00%2026-06-30
Jaya Lalit Mehta00%2026-06-30
Rupal Rajesh Mehta00%2026-06-30
Falguni Kaushal Mehta00%2026-06-30
Megh Rajesh Mehta00%2026-06-30
Kalpana Premal Mehta00%2026-06-30
Maitri Megh Mehta00%2026-06-30
Sangeetha S00%2026-06-30
Lalit Kumar V Jain00%2026-06-30
Board of Directors
NameDesignationYear
Lalit MehtaChairman & Managing Director2025
Rajesh MehtaED / WTD / CFO / Promoter2025
Megh MehtaWhole Time Executive Director2025
Manishkumar PipaliaIndependent Non Exe. Director2025
Sachin KotharyIndependent Non Exe. Director2025
Megha JainIndependent Non Exe. Director2025
Piyush DharodIndependent Non Exe. Director2025
Nishant KankariaCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10533
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-14Board Meetings—
dividend2025-09-18₹1 (10%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000101
2025000101
2025000101
Company Information
Incorporated1992
ChairmanLalit Mehta
AuditorShah & Savla LLP
Investor Email[email protected]
🌐 www.samratpharmachem.com ↗

📍 Plot No A2/3445, GIDC Phase IV, Ankleshwar, Gujarat, 393002

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Faze ThreeAce Edutrend Ltd.Anupam Finserv LimitedRaj Packaging IndustriesPrivi Speciality ChemicalsNatraj Proteins Ltd.NPR Finance Ltd.Amco India Ltd.Kreon Finnancial ServicesGyan Developers & BuilderKisan Mouldings Ltd.Vijay Textiles Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search